No Data
No Data
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Optinose Reports Revenue Growth Amid Financial Challenges
OptiNose | 10-K: FY2024 Annual Report
OptiNose Inc. Q4 Loss Decreases, Beats Estimates
OptiNose | 8-K: Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
Express News | OptiNose Q4 Income From Operations USD 354 Thousand